Home Contact Us 中文 English
Yourlocation:Home >News> Analysis of the effect of low - dose Etazolam combined with trimebutine maleate in the treatment of gastrointestinal neurosis

Analysis of the effect of low - dose Etazolam combined with trimebutine maleate in the treatment of gastrointestinal neurosis

Time:2017/8/4 18:07:35

To explore the clinical effect of low dose of Etazolam combined with trimebutine maleate in the treatment of gastrointestinal neurosis.

The patients were divided into control group and experimental group according to the method of random assignment. The patients were divided into control group and experimental group. The patients were divided into control group and experimental group. 40 cases, in which the control group of patients with low-dose Etazolam treatment, the experimental group of patients with low-dose Etazolam combined with trimebutine maleate treatment, comparative analysis of the two groups of patients with clinical treatment.

The effective rate of clinical treatment in the experimental group was higher than that in the control group. There was significant difference between the two groups in the data of the two groups, which was statistically significant (P <0.05).

The combination of low-dose Etazolam and trimebutine maleate in the treatment of gastrointestinal neurosis can improve the clinical efficacy of patients and have the value of promotion and use.